A03.2
Shigellosis due to Shigella boydii
Clinical Classification Guidelines
Inclusion Terms
- Group C shigellosis
Medical Intelligence & Overview
Shigellosis caused by Shigella boydii, classified under ICD-10 code A03.2, is an infectious disease characterized by intestinal illness resulting from bacterial infection. As part of Group C shigellosis, this condition predominantly affects the gastrointestinal tract and is notable for its contagious nature. Recognizing the symptoms and understanding the causes can aid in early detection and management.
Causes & Symptoms
Clinical Causes: Ingestion of contaminated food or water containing Shigella boydii bacteria Contact with an infected person, especially through poor hygiene practices Exposure to contaminated surfaces or objects Travel to regions with inadequate sanitation systems where the bacteria are prevalent
Key Symptoms: Diarrhea, often with blood or mucus Abdominal cramps and pain Fever and chills Nausea and vomiting Sometimes, dehydration due to fluid loss
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves stool tests to identify the presence of Shigella bacteria. Healthcare providers may also perform blood tests or stool cultures to confirm infection and determine the specific bacterial strain. Medical history and symptom assessment are essential components of the diagnostic process.
Treatment Protocols: Treatment primarily involves maintaining hydration and electrolyte balance. Antibiotics are often prescribed to help eliminate the bacteria and reduce the duration of illness. Supportive care, including rest and dietary adjustments, may also be recommended. In some cases, hospitalization may be necessary for severe dehydration or complications.
Clinical Advice & FAQs
Billing Guidance
Is A03.2 a billable ICD-10 code?
Yes, A03.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A03.2?
Clinical documentation must specify the nature of Shigellosis due to Shigella boydii and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
